Enovix Corporation (ENVX) Stock Forecast & Price Target

Enovix is supported by a compelling commercialization pipeline that now has smart eyewear generating initial revenue, a 50,000-pack order with about 19,000 packs expected in 3Q26, and a Korea defense, drone and industrial pipeline that expanded 41% to $183M. Its lead smartphone customer has cleared more than 1,000 cycles under the accelerated test, leaving only the final qualification step expected in 4Q26, which strengthens confidence that the silicon-anode platform can scale into a much larger market. Although losses persist, management expects revenue to rise from $9.0M in 2Q26 to $9.0M-$10.0M in 3Q26 and then accelerate meaningfully, while gross margin improved to 19.9% and manufacturing yields continue to trend higher.

Enovix is viewed negatively because its commercialization story remains unproven, with management still focused on customer qualification, smartphone testing, and manufacturing improvements while acknowledging that the battery architecture has yet to be mass-produced effectively at scale. Near-term fundamentals also look weak, as the Q3 forecast calls for just $9.5M of revenue and a ($0.14) adjusted EPS, alongside meaningful execution risk from the August CEO departure and ongoing leadership transition. Liquidity and funding pressure further cloud the outlook, since the model shows $402.3M of cumulative FCF outflows across 2026, 2027, and 2028, only about $42.8M of unrestricted cash and investments at year-end 2028, and potential dilution if external financing is required.